Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial Post author:Sam Post published:February 7, 2018 Post category:BioPharma MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace You Might Also Like New Biotech Incubator Emerges in Washington, Aims to Create Jobs and Hub Outside of Seattle April 16, 2017 AmerisourceBergen Pays $815M Cash for Drug Wholesaler H. D. Smith November 20, 2017 <b>Aviva</b> Invests In Owlstone Medical Breath Biopsy Platform March 26, 2017
New Biotech Incubator Emerges in Washington, Aims to Create Jobs and Hub Outside of Seattle April 16, 2017
